Navigation Links
Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020
Date:10/18/2011

pth analysis of Gardasil including efficacy, safety, pricing, competition and other details which influence its sales potential

- Detailed sales forecasts for 2006-2020 for Gardasil in the US and EU5

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of competition by understanding the changing competitive landscape

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of the drug's performance

- Examine the historical sales performance of a drug in seven major markets

- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

1 Table of contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 Cervical Cancer Vaccines Market 4

2.2 Epidemiology 4

2.3 Etiology 6

2.3.1 HPV Infections 6

2.3.2 Lack of Regular Papanicolaou (pap) Tests 7

2.3.3 Smoking 7

2.3.4 Sexual History 8

2.3.5 Birth Control Pills 8

2.4 GlobalData Report Guidance 8

3 Cervical Cancer Vaccines: Market Characterization 9

3.1 Cervical Cancer Vaccines Market 9

3.2 Drivers and Challenges for the Cervical Cancer Market 9

3.2.1 Drivers for Cervical Cancer Vaccine Market 9

3.2.2 Challenges for Cervical Cancer Vaccines 10

4 Gardasil (human papillomavirus vaccine(types6,11,16,18)) 11

4.1 Introduction 11

4.2 Human Papillomavirus Vaccine (HPV) 11

4.3 Mechanism of Action 11

4.4 Clinical Studies of Gardasil 11

4.4.1 Phase I and II trial 11

4.4.2 Phase III trial 12

4.5 Factors Affecting Sales 12

4.5.1 Cervical Cancer Market 12

4.5.2 Better Efficacy 13

4.5.3 Wide Disease Coverage
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA: Gardasil Approved to Prevent Anal Cancer
2. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
5. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
6. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
7. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
8. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
11. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... NASHVILLE, Tenn. , Dec. 17, 2014  Strategic ... health management software solutions, today announced a strategic agreement ... the New Jersey regional marketplace.  ... and enhance the health and wellness solutions QualCare brings ... and the surrounding region. QualCare ...
(Date:12/17/2014)... ANGELES , Dec. 17, 2014  ImmunoCellular ... the US Patent and Trademark Office (USPTO) has ... ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six ... The claims of US Patent No. 8,871,211, which ... neural cancer by administering a dendritic cell composition ...
(Date:12/15/2014)... LONDON , December 15, 2014 /PRNewswire/ ... Am 19. und 20. Februar ... das Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ... zu besuchen. Diese Tagung ... Gemeinschaft die Möglichkeit geben, die neue profitablen ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... Switzerland, September 15, 2010 ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... 14 ThermoGenesis Corp. (Nasdaq: KOOLD ), a ... store adult stem cells, said today that revenues for the ... of $4.0 million for the same quarter a year ago. ... million. The Company recorded disposable revenues of $4.8 ...
Cached Medicine Technology:ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk 2ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk 3ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk 4ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk 5ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk 6ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk 7ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 2ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 3ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 4ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 5ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 6ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 7
(Date:12/17/2014)... parents should leave prenatal picture-taking to medical professionals, the ... ultrasound imaging and heartbeat monitors to get "keepsake" images ... "Although there is a lack of evidence ... monitors, prudent use of these devices by trained health ... engineer, said in an agency news release. "Ultrasound ...
(Date:12/17/2014)... Kathleen Doheny HealthDay ... Chronic sleep loss is rampant in America, and work commitment ... is the No. 1 sleep killer," said Dr. Mathias Basner, ... the University of Pennsylvania Perelman School of Medicine. A ... older, found that work is the main activity exchanged for ...
(Date:12/15/2014)... Palm Beach, FL (PRWEB) December 15, 2014 ... Care , knows that holidays can be a daze of ... From slips and falls while decking halls, to burns when ... plenty of holiday hazards that can happen at any time. ... for pain, MD Now has made a list of helpful ...
(Date:12/15/2014)... 2014 (HealthDay News) -- Expert pilots process visual information ... they make better decisions during landings, a new study ... techniques for pilots to master, and 36 percent of ... occur during final approach and landing. Researchers monitored ... moderately experienced pilots while they were at the controls ...
(Date:12/15/2014)... December 15, 2014 At the leading, ... AutismOne and Focus Autism will ... with research on the effects of toxins to children’s ... intervention information. , Luminaries such as Dr. Lucija ... abroad with esteemed, credentialed colleagues of the United States ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... , The inactivity or "silence" of certain genes ... leukemia as well as in response to treatment, according to ... specialists from the University Hospital of Navarra and the Center ... as well as the Reina Sofa Hospital in Cordoba, Andalusia. ...
... Company, the nation,s leading builder of healthcare facilities, has ... with the $42 million Phase Two expansion to the ... in March 2009 with completion scheduled for March 2011. ... emergency rooms, ICU, CCU, three operating rooms and 26 ...
... Link as SCHIP Legislation Signed Into LawWASHINGTON, Feb. ... voice for more than 36,000 frontline providers of ... commended President Barack Obama for singling out the ... signed an historic expansion of the State Children,s ...
... missed key DNA variant, researchers say , , FRIDAY, Feb. ... DNA called copy number variants may play a role ... findings support a sharp change of direction in genetics ... decades, researchers have identified dozens of genes and single ...
... ,History Shows Avalon Is No Champion of Corporate Governance,TUCSON, ... PRSC ) today commented on the recent ... Inc. (Pink Sheets: CITY) together with other related persons, ... sole director of Avalon, intends to initiate a consent ...
... Feb. 6 ev3 Inc. (Nasdaq: EVVV ) ... and its financial guidance for 2009 on Tuesday, Febuary 24, ... conference call and webcast the same day at 7:30 a.m. ... review its fourth quarter and full-year operating results and future ...
Cached Medicine News:Health News:New genes involved in acute lymphoblastic leukemia play fundamental role in prognosis of the disease 2Health News:Turner to Manage Construction of $42 Million Expansion of Northern Inyo Hospital in Bishop, Calif. 2Health News:Doctors of Optometry Cheer Obama's Call to Action on Children's Vision 2Health News:Doctors of Optometry Cheer Obama's Call to Action on Children's Vision 3Health News:Genome Study Points to New Culprit for Schizophrenia 2Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 2Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 3Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 4Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 5Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 6Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 7Health News:ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009 2
... Clearly, the ISI Lexan ... versatile surgical table for lower ... orthopaedic, head and neck, and ... optional traction package gives you ...
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
For general purposes...
... BcMag Streptavidin magnetic beads are ... of biotinylated molecules such as ... from cell lysates or hybridization ... highly dispersed, it can also ...
Medicine Products: